Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.40 – $4.56
34% from low
Exchange
OTC Link
ADRC
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $476.1M | $506.1M | $202.9M | $340.2M | $350.3M | $354.0M | $290.4M | $250.2M |
| Cost of revenue | $349.0M | $367.0M | $125.4M | $204.7M | $208.5M | $216.0M | $180.9M | $204.1M |
| Gross profit | $127.1M | $139.2M | $77.6M | $135.5M | $141.7M | $138.1M | $109.5M | $46.1M |
| Gross margin | 26.7% | 27.5% | 38.2% | 39.8% | 40.5% | 39.0% | 37.7% | 18.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $9.3M | −$7.7M | −$4.9M | −$11.7M | $1.9M | −$14.3M | −$11.8M | −$3.3M |
| EBITDA | $19.2M | −$5.1M | $783.0K | −$5.3M | $6.5M | −$8.8M | −$10.3M | −$1.1M |
| Net income | $7.4M | −$9.4M | $8.2M | −$10.0M | $2.4M | −$17.4M | −$20.8M | −$4.9M |
| Net margin | 1.6% | -1.9% | 4.0% | -3.0% | 0.7% | -4.9% | -7.2% | -2.0% |
| EPS (diluted) | 0.40 | -0.52 | -0.21 | -0.56 | 0.13 | -0.96 | -1.12 | -0.27 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $185M | $0.02 | $0.02–$0.02 | 1 |
| 2028 | $182M | $0.05 | $0.05–$0.05 | 1 |
Forward consensus · source: Financial Modeling Prep
NAKED WINES PLC UNSP/ADR
No one on the platform currently holds MJWNY.
No tracked institution reports a position in MJWNY as of their last filing.
No one on the platform has traded MJWNY yet.
| $3635 |
| — |
| KPTSFKP Tissue Inc. | $9.60 | +0.00% | $96M | — |
| OGOFFOrganto Foods Inc. | $0.48 | -1.70% | $76M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 0.3× historical median P/S.
Fair value ≈ $9.29 · price $3.80 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.